Acylated 4-amidinoand 4-guanidinobenzylamines for the inhibition of plasma kallikrein

Details for Australian Patent Application No. 2004204358 (hide)

Owner Curacyte Chemistry GmbH

Inventors Sturzebecher, Jorg; Steinmetzer, Torsten; Shweinitz, Andrea

Agent Watermark

Pub. Number AU-A-2004204358

PCT Pub. Number WO2004/062657

Priority 103 01 300.8 15.01.03 DE

Filing date 15 January 2004

Wipo publication date 29 July 2004

International Classifications

A61K 031/198

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 009/02 Drugs for disorders of the cardiovascular system

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 037/00 Drugs for immunological or allergic disorders

A61P 037/08 Drugs for immunological or allergic disorders

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61K 031/401 - Proline

A61K 031/435 - having six-membered rings with one nitrogen as the only ring hetero atom

Event Publications

4 August 2005 PCT application entered the National Phase

  PCT publication WO2004/062657 Priority application(s): WO2004/062657

16 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004204362-Multi-layered electrochemical microfluidic sensor comprising reagent on porous layer

2004204355-PDE4 inhibitors for the treatment of neoplasms of lymphoid cells